Dear Sir, The relations between thrombopoietin (c-mpl ligand), megakaryocytopoietic cytokines and pathological megakaryocytopoie-sis comprise an enigmatic complex [1] . We read the article by who reported a case of leukemia with megakaryocytic differentiation following essential thrombocythemia and myelofïbrosis. It was very interesting to note that this patient with increased megakaryocytic proliferation had a deletion of the long arm of chromosome 5 (5q-). The association between a clonal he-matologic disorder characterized by hypolo-bulated micromegakaryocytic hyperplasia and a clonal cytogenetic anomaly consisting of 5q-is well-known. Increased megakaryocytic proliferation with characteristic morphology and the concomitant presence of normal or high platelet counts and leukope-nia are the specific features of the 5q-syndrome [3, 4] . However, the exact mechanism causing these features still represents a dilemma. We had recently reported a possible cytokine mechanism of increased megakaryocytic proliferation with undetectable IL·4 and increased IL-6 levels in 5q deletion [5] . The proliferation and differentiation of hematopoietic cells is under the control of specific growth factors. Several major hematopoietic growth factors, including IL-4, acting on myeloid progenitors are located on the long arm of chromosome 5. On the other hand, the megakaryocytopoietic cytokine, IL·6, which seems to be responsible for me-gakaryocytopoiesis in many cases of reactive thrombocytosis is located in 7pl5 [6, 7] . IL-4 may function directly as a negative regulator of megakaryocytopoiesis, and also inhibits IL-6 synthesis and suppresses IL-6 production in vitro [8] . Increased IL-6 concentration might be due to decreased IL-4 synthesis caused by the deletion of 5q. IL·6, which has a chromosomal location of 7pl5, is a well-known megakaryocyte potentiator [7, [9] [10] [11] [12] . Consequently, leukopenia and thrombocytosis in the 5q-syndrome may be explained by cytokine interactions diminished by the deletion of the long arm of chromosome 5. It would be very interesting to determine megakaryocyte-related interleuReferences Haznedaroglu ÍC, Benekli M, Dündar SV: Thrombopoietin, megakaryocytopoietic cytokines, and reactive versus clonal megakaryocytopoiesis: An enigma complex. Blood 1996;87: 1654.
